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Background. 'ere are very few epidemiological studies investigating Parkinson’s disease (PD) in Africa. 'e hundreds of local
languages and dialects make traditional screening and clinical evaluation tools difficult to use.Objective. 'e objective of the study
was to validate two commonly used PD questionnaires in an African population. Methods. 'e PD Screening Questionnaire
(PDSQ) and Parkinson’s Disease Questionnaire (PDQ-39) weremodified and translated into Afrikaans, Setswana, and isiZulu and
administered to a sample of healthy local residents. We assessed the internal consistencies and cluster characteristics of the
questionnaires, using a Cronbach’s alpha test and exploratory factor analysis. 'e questionnaires were then administered to a
population-based sample of 416 research participants. We evaluated the correlations between the questionnaires and both a timed
motor task and the Unified Parkinson’s Disease Rating Scale motor subsection 3 (UPDRS3), using locally weighted scatterplot
smoothing (LOWESS) regression analysis and Spearman’s rank correlation. Results. Both questionnaires had high overall internal
consistency (Cronbach’s alpha = 0.86 and 0.95, respectively). 'e modified PDQ-39 had evidence of five subscales, with Factor 1
explaining 57% and Factor 2 explaining 14%, of the variance in responses. 'e PDSQ and PDQ-39 scores were correlated with the
UPDRS3 score (ρ= 0.35, P< 0.001; and ρ= 0.28, P< 0.001, respectively). Conclusion. 'e translated PDSQ and PDQ-39
questionnaires demonstrated high internal consistency and correlations with clinical severity of parkinsonism and a timed motor
task, suggesting that they are valid tools for field-based epidemiological studies.
1. Introduction
'e global impact of Parkinson’s disease (PD) is expected to
reach pandemic proportions with the aging of both devel-
oped and developing country populations [1–4]. As life
expectancy on the African continent increases, neurode-
generative diseases are becoming a growing public health
concern. Population-based epidemiological studies of neu-
rodegenerative disease in Africa are rare, and there are
limited data from the 21st century [5]. Screening tools
designed and validated in the developed world, primarily in
English, are not appropriate for much of Africa where there
are hundreds of local languages and dialects [6], making
screening for PD or parkinsonism using questionnaires
validated in countries such as the USA and the UK
challenging.
South Africa has the second largest economy in Africa
[7] and a predominantly black population with increasing
life expectancy [8].'e country has a dynamic academic and
healthcare environment and the skills and infrastructure to
conduct world-class scholarly activities and provide modern
healthcare services. 'ere are 11 official languages, and PD
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researchers must address this barrier in order to conduct
quality Parkinson’s disease (PD) research in South Africa.
'e questionnaires used in developed countries are usually
self-administered in English. However, in the South African
setting, due to language and literacy challenges, the ques-
tionnaires are administered by field workers and are thus
subject to misinterpretation when translated. Similarly,
some questions do not easily translate from English, and
several concepts are not easily translated into African
languages.
To ensure that the questions are clear and unambiguous
to study participants, it is essential that the English versions
be modified, translated into, and validated in vernacular
languages where relevant. Failure to do this limits our
understanding of disease burden and isolates large pop-
ulations from the drug development process, in which drugs
may perform differently than in predominantly white En-
glish-speaking populations in developed countries.
We validated two commonly used PD questionnaires: a
PD Screening Questionnaire (PDSQ) [9] and the 39-item
questionnaire that assesses self-reported PD-specific health-
related quality of life over the last month (PDQ-39) [10], to
screen research participants in a field-based epidemiological
study of the relationship between environmental manganese
(Mn) exposure and parkinsonism. 'e study population
resides near one of the largest Mn smelters in the world. We
report the modification and validation of these two ques-
tionnaires in English and three of the most commonly
spoken languages in South Africa: Setswana, isiZulu and
Afrikaans.
2. Methods
'eHuman Research Ethics Committee of the University of
theWitwatersrand (ethics clearance certificate no. M141153)
and the Human Research Protection Organization of
Washington University approved the study.
'e PD Screening Questionnaire comprises nine ques-
tions to elicit self-reported symptoms typical of PD to screen
populations for PD, answered as “yes” or “no.” It has been
widely used in epidemiological studies. 'e PDQ-39 is a
validated PD-specific quality of life questionnaire comprised
of 39 questions that assess mobility, activities of daily living,
emotional well-being, stigma, social support, cognitions,
communication, and bodily discomfort in patients with PD.
Answers are based on a 5-point Likert scale (never, occa-
sionally, sometimes, often, and always or cannot do at all).
'e UPDRS3 quantifies motor features of PD on a 0–108
scale with higher scores indicating more severe
parkinsonism.
We used a three-step validation process to validate the
two questionnaires: translation and face validity, content
validity, and construct validity.
In the first step, we modified and translated several
questions in the English versions of the questionnaires, in
accordance with methods described by Aaronson et al. [11].
'e questions were modified without changing the infor-
mation they attempt to elicit, in order to make them un-
derstandable to English-speaking South Africans, in terms of
both language and content. 'e modified questionnaires
were reviewed for accuracy and appropriateness, after which
individuals proficient in three of the most common South
African languages (Setswana, isiZulu, and Afrikaans) then
translated them. 'e questionnaires were back-translated by
different individuals, also proficient in the respective
languages.
In the second step (content validation), we tested the per-
formance of the translated questionnaires in 16 English-, Af-
rikaans-, Setswana-/Sotho-, and isiXhosa-/isiZulu-speaking
male and female volunteers with varying educational achieve-
ments. Setswana and Sotho are linguistically similar and have
similar origins, as have isiXhosa and isiZulu which are both
Nguni languages. Interviewers who were fluent in the relevant
languages were trained by skilled qualitative researchers to
administer the questionnaires, face to face. 'e interviewers
recorded participants’ responses to each question and asked
them to clarify their thought processes in order to elicit what
they understood by each question. Probing was used to obtain a
detailed narrative of the cognitive process of each participant
before he/she answered a question. 'e interviews were audio-
recorded, transcribed verbatim, and translated into English.
Based on the results of these cognitive interviews,minor changes
were made to the questionnaires. For example, in almost all
South African vernacular languages, there is no single word for
“balance”. 'us, in the PDSQ, the question “Is your balance
poor?” was changed to “Is your balance poor when walking?”.
'e two questionnaires were then administered to a conve-
nience sample of 160 individuals, older than 40 years, from a
residential area in theMidvaal region of SouthAfrica, who spoke
one of the four languages (40 per language) to assess the internal
consistency of the questionnaires and to determine if the PDSQ
and PDQ-39 retained their item cluster characteristics.
In the third step (construct validity), we administered the
questionnaires, face to face, to 416 participants in a pop-
ulation-based study of the health effects of environmental
Mn exposure. All participants were older than 40 years and
were local residents, living near a ferromanganese smelter.
Local, trained fieldworkers recruited study participants,
using a random household sampling method. Performances
on the PDQ-39 and PDSQ were validated against two
methods of assessing motor function: (1) a Purdue Grooved
Pegboard timed test [12] was used to measure fine motor
speed and visuomotor coordination (times taken to com-
plete the task with the dominant and nondominant hand
were recorded), and (2) the Unified Parkinson’s Disease
Rating Scale motor subsection 3 (UPDRS3) [13] was ad-
ministered by a movement disorders specialist without
knowledge of the responses in either questionnaire.'e tests
and tools are described in Supplementary Table S1.
2.1. Statistical Analysis. We performed all statistical analyses
using Stata MP version 14.2 (StataCorp LP, College Station,
Texas). 'e internal consistencies of both the PDSQ and the
PDQ-39 were assessed using a Cronbach’s alpha test; in-
ternal consistency was considered acceptable when α> 70,
based on the 160 completed questionnaires. For the PDQ-39,
we calculated the internal consistency of the eight subscales
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in the original questionnaire. To determine if the two
questionnaires retained their original subscale structures
(one for PDSQ and eight for PDQ-39), we used exploratory
factor analysis with an orthogonal rotation (Varimax) to
explore how many factors the items loaded onto the
modified and translated versions of the questionnaires.
Exploratory factor analysis provides procedures for deter-
mining an appropriate number of factors and the patterns of
loadings from the data [14]. We used an eigenvalue >1.0 as
the threshold for a domain (i.e., subscale) [15–17]. We then
recalculated the internal consistency of the five subscales that
were identified through the exploratory factor analysis.
To investigate the association between UPDRS3 scores
and age, grooved pegboard times (dominant and non-
dominant hand), PDQ-39 score, and PDSQ score, we first
graphically evaluated these associations using locally
weighted scatterplot smoothing (LOWESS) regression
analysis. We also compared the performance of the PDSQ in
relation to the PDQ-39. We again graphically evaluated this
association using LOWESS regression analysis and evaluated
correlations using Spearman’s rank correlation, with sig-
nificance at α= 0.05.
3. Results
'e demographic characteristics of the study participants in
the content and construct validity steps are described in
Table 1. In both the content and construct validity com-
ponents, the majority of study participants were female
(61.5% and 58.9%, respectively). 'e mean ages of the two
study populations were 50.9± 10.0 (range 33–79) years and
51.2± 9.4 (range 38–97) years, respectively.
'e mean UPDRS3 score of those who participated in
the construct validity component (N= 416) was 10.1± 7.8
(Table 2). 'e range of scores associated with the PDSQ and
the PDQ-39 was wide (0–52). Participants with higher
UPDRS3 scores were older (ρ= 0.30, P< 0.001) and took
longer to complete the grooved pegboard test (dominant
hand ρ= 0.39, P< 0.001; nondominant hand ρ= 0.39,
P< 0.001).
'e mean PDSQ score was 0.63± 1.85 for the English-
speaking participants, 0.73± 1.47 for the Afrikaans-speaking
participants, 2.48± 2.99 for the Setswana-speaking partici-
pants, and 3.15± 3.47 for the isiZulu-speaking participants.
'e differences were statistically significant (F= 8.41,
P< 0.001). Factor analysis for the modified PDSQ demon-
strated loading on one factor (eigenvalue 3.81), consistent
with assessing a single clinical domain. 'e PDSQ had high
overall internal consistency (Cronbach’s alpha = 0.86); the
individual questions also demonstrated high internal con-
sistency (Cronbach’s alpha range = 0.83–0.86), suggesting
that a participant’s response to one question was related to
his/her response to other questions in the PDSQ (Table 3).
'e PDQ-39 scores differed by language: 57.25± 17.82 for
the English, 55.41± 18.19 for the Afrikaans, 63.76± 17.64 for
the Setswana, and 70.95± 33.41 for the isiZulu group (F=2.84;
P � 0.04). Factor analysis demonstrated that, instead of the
eight subscales in the original PDQ-39, the modified PDQ-39
had five subscales, with Factor 1 (eigenvalue= 14.08) explaining
65% of the variance in responses, Factor 2 explaining 15%
(eigenvalue= 3.30), Factor 3 explaining 9% (eigenvalue= 1.94),
Factor 4 explaining 6% (eigenvalue= 1.42), and Factor 5
explaining 6% (eigenvalue= 1.21) across all participants. 'e
five subscales comprised (1) mobility, out-of-house, and ac-
tivities of daily living; (2) emotional well-being; (3) cognitive-
communication-body discomfort; (4) activities of daily living
inside the house (ADL); and (5) items relating to eating and
drinking in public, problems in relationships, and uninten-
tionally falling asleep (Table 4). 'e modified and translated
PDQ-39 questionnaire demonstrated high overall internal
consistency (Cronbach’s alpha=0.95). However, the individual
subscales had variable internal consistency (Table 5). Subscales
for mobility (α=0.9), activities of daily living (α=0.82),
emotional well-being (α=0.9), and body discomfort (α=0.83)
demonstrated good to excellent internal consistency. Social
support (α=0.78), cognition (α=0.79), and stigma (α=0.74)
had acceptable internal consistency. Communication (α=0.69)
demonstrated marginal internal consistency.
'e UPDRS3 scores were positively correlated with both
the PDSQ (ρ� 0.30; P< 0.001) and the PDQ-39 (ρ� 0.22;
P< 0.001) scores, indicating that, in general, those with
more severe parkinsonism had more PD symptoms and
poorer PD-specific health-related quality of life (Figure 1).
'e PDQ-39 and PDSQ scores were strongly correlated
(ρ� 0.64; P< 0.001) (Figure 1).
4. Discussion
In this multistep validation study, we demonstrated that the
two questionnaires (the PDSQ and the PDQ-39) retained
their original meanings and had good internal consistency
once modified and translated for the most common South
African languages. Moreover, we demonstrated strong
correlations between severity of parkinsonism and PD
symptoms as well as PD-specific health-related quality of
life, suggesting that the questionnaires performed as ex-
pected when compared to a clinical measure of severity. 'e
PDSQ was originally designed for use in epidemiological
studies to identify people with PD, due to the high cost of
this expert assessment in large populations [18]. While the
purpose of the population-based study focuses on identi-
fying parkinsonism in an environmentally exposed pop-
ulation, the PDSQ performed as expected, given that the
number of affirmative answers was positively associated with
the UPDRS3 score.'emodified PDQ-39 also demonstrated
good internal consistency and was strongly correlated with
motor signs of parkinsonism in the population-based study
(the PD-specific questions were omitted). Overall, we pro-
vided evidence that these two modified questionnaires are
valid screening tools for use in field-based epidemiological
studies and may augment data obtained from a clinical
specialist’s examination.
'e use of the PDSQ questionnaire in the population-
based study is largely consistent with the original,
intended use of this tool as a screening questionnaire in
epidemiological studies. However, we used parkinsonism
as a continuous measure of a health outcome, as opposed
to a diagnosis of PD. 'is approach is better suited to
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investigating associations between motor signs of par-
kinsonism and environmental exposures in population-
based studies of adults. A recently published study in
Xhosa-speaking South Africans found that only 18% of
the participants could correctly identify a patient with PD
from a video [19]. Although we focused on Setswana- and
isiZulu-speaking South Africans, PD awareness in these
groups is likely to be similar. Nevertheless, the symptoms
in the modified PDSQ appeared to be recognized by the
participants, and those with higher scores on the PDSQ
tended to also have higher UPDRS3 scores. Further re-
search is needed to determine if these modified African
Table 2: Measurement scores obtained by participants (construct validity step).
Measurement n Mean SD Min Max
UPDRS3 416 10.1 7.8 0 52
Dominant hand Grooved Pegboard time 414 106.7 44.7 43.2 300
Nondominant hand Grooved Pegboard time 408 116.9 47.7 51.4 300
PDQ-39 412 33.1 21.3 0 115
PDSQ 416 1.9 2.1 0 8
UPDRS3, Unified Parkinson’s Disease Rating Scale motor subsection 3; PDQ-39, Parkinson’s Disease Questionnaire; PDSQ, Parkinson’s Disease Screening
Questionnaire; SD, standard deviation.
Table 3: Internal reliability (Cronbach’s alpha) of the modified PDSQ.
Question n Alpha
Do you have trouble rising from a chair? 160 0.85
Is your handwriting smaller than it once was? 160 0.85
Do people tell you that your voice is too soft? 159 0.86
Is your balance poor? 158 0.84
Do your feet suddenly seem to get stuck when turning or in doorways? 160 0.83
Do people tell you that you have a blank look on your face? 158 0.85
Do your arms or legs shake? 156 0.84
Do you have trouble doing up your buttons? 157 0.85
Do you shuffle your feet or take tiny steps when you walk? 159 0.83
Overall Cronbach’s alpha 0.86
PDSQ, Parkinson’s Disease Screening Questionnaire.






n % n %
Sex
Male 60 38.5 171 41.1
Female 96 61.5 245 58.9
Education
None 2 1.4 59 14.8
Primary school 15 10.4 98 24.6
Secondary school 96 66.7 229 57.4
Tertiary 31 21.5 13 3.3
Home language
English 40 26.0 1 0.3
Afrikaans 37 24.0 4 1.1
Sotho 46 29.9 234 62.6
isiXhosa 9 5.8 55 14.7
Setswana 4 2.6 14 3.7
isiZulu 18 11.7 66 17.7
Ever smoked
Yes 44 28.9 147 35.3
No 108 71.1 269 64.7
Ever consumed alcohol regularly
Yes 53 34.2 226 54.3
No 102 65.8 190 45.7
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language questionnaires have sufficient sensitivity and
specificity to be used as screening questionnaires to
identify those with PD. However, in this environmental
health research setting, the questionnaires performed
well.
While our study is not the first to attempt to validate the
PDQ-39 in non-English languages, our aim to determine the
association between an environmental exposure- and PD-
specific quality of life is unique.We previously demonstrated
higher scores on the PDQ-39 in those with occupational Mn
exposure and UPDRS3≥15 [20]. In this environmental Mn
exposure study, we found similar associations between the
modified PDQ-39 and severity of parkinsonism, demon-
strating a consistency across different Mn-exposed pop-
ulations. While the modified PDQ-39 retained the
anticipated association with parkinsonism, the clustering of
questions (subscales) differed from the original British
version of the questionnaire [10]. Interestingly, a validation
study in which the PDQ-39 was modified from British
English to American English also changed the questionnaire
item cluster characteristics, finding that mobility-stigma-
cognition, ADL-communication-body discomfort, and well-
Table 4: Internal reliability (Cronbach’s alpha) of the modified PDQ-39.
Subscale/item n Alpha
Mobility 0.90
Had difficulty doing the leisure activities you would like to do? 160 0.95
Had difficulty looking after your home, e.g. repairs, housework, cooking? 159 0.95
Had difficulty carrying bags of shopping? 160 0.95
Had problems walking to the shops or church? 157 0.95
Had problems walking to your nearest neighbor? 159 0.95
Had problems getting around the house as easily as you would like? 160 0.95
Had difficulty getting around the community? 160 0.95
Needed someone else to help you when you leave the house? 160 0.95
Felt frightened or worried about falling over in public? 158 0.95
Been stuck in the house more than you would like? 160 0.95
Activities of daily living 0.82
Had difficulty washing yourself? 159 0.95
Had difficulty dressing yourself? 160 0.95
Had problems doing up your shoelaces? 160 0.95
Had problems writing clearly? 160 0.95
Had difficulty cutting up food? 158 0.95
Had difficulty holding a drink without spilling it? 160 0.95
Emotional well-being 0.90
Felt depressed? 160 0.95
Felt isolated and lonely? 158 0.95
Felt weepy or tearful? 158 0.95
Felt angry or bitter? 157 0.95
Felt anxious? 157 0.95
Felt worried about your future? 159 0.95
Stigma 0.74
Avoided eating or drinking in public? 158 0.95
Felt worried by other people’s reaction to you? 160 0.95
Social support 0.78
Had problems with your close personal relationships? 160 0.95
Lacked support in the ways you need from your spouse or partner? 157 0.95
Lacked support in the ways you need from your family or close friends? 148 0.95
Cognition 0.79
Unintentionally fallen asleep during the day? 147 0.95
Had problems concentrating, e.g. when reading or watching TV? 157 0.95
Felt your memory was bad? 158 0.95
Had distressing dreams or hallucinations? 159 0.95
Communication 0.69
Had difficulty with your speech? 160 0.95
Felt unable to communicate with people properly? 156 0.95
Felt ignored by people? 157 0.95
Bodily discomfort 0.83
Had painful muscle cramps or spasms? 159 0.95
Had aches and pains in your joints or body? 158 0.95
Felt unpleasantly hot or cold regardless of the weather? 159 0.95
PDQ-39, Parkinson’s Disease Questionnaire.
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being-social support clustered together [21]. Overall, the
agreement between the subcategories of the PDQ-39 was
excellent, but social support, stigma, and communication
were outliers, potentially due to ethnic differences in our
study population. For example, questions categorized as
stigma and social support in the British and American
versions of the questionnaire had a very different context for
the black South African research participants. Older black
South Africans often live with extended families and might
not need support from a spouse/partner, which might in-
fluence the relationships between questions. 'e stigma
questions were not asked unless the study participant said
that he/she had a diagnosis of PD; this might have impacted
the agreement with the rest of the questionnaire. In addition,
very few study participants indicated that they had been
diagnosed with PD, which could also have reduced the
internal reliability. 'e questions about stigma might not be
essential in population-based epidemiological studies. 'e
Table 5: Factor loadings for the five subscales of the modified PDQ-39.
Subscale/items Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Uniqueness
Mobility
Had difficulty doing the leisure activities you would like to do? 0.5068 0.4312
Had difficulty looking after your home, e.g. repairs, housework,
cooking? 0.6701 0.4060
Had difficulty carrying bags of shopping? 0.6524 0.3564
Had problems walking to the shops or church? 0.7854 0.2754
Had problems walking to your nearest neighbor? 0.6493 0.3560
Had problems getting around the house as easily as you would like? 0.5024 0.5076 0.4437
Had difficulty getting around the community? 0.4831
Needed someone else to help you when you leave the house? 0.6774 0.4535
Felt frightened or worried about falling over in public? 0.7081 0.3084
Been stuck in the house more than you would like? 0.6207 0.3828
Activities of daily living
Had difficulty washing yourself? 0.8342 0.2364
Had difficulty dressing yourself? 0.8414 0.2301
Had problems doing up your shoelaces? 0.7047 0.3311
Had problems writing clearly? 0.8624
Had difficulty cutting up food? 0.5278 0.5812
Had difficulty holding a drink without spilling it? 0.6658 0.4081
Emotional well-being
Felt depressed? 0.5982 0.4076
Felt isolated and lonely? 0.7209 0.2780
Felt weepy or tearful? 0.7222 0.3093
Felt angry or bitter? 0.6391 0.3011
Felt anxious? 0.7564 0.2631
Felt worried about your future? 0.4039
Stigma
Avoided eating or drinking in public? 0.6980 0.3548
Felt worried by other people’s reaction to you? 0.5338 0.3381
Social support
Had problems with your close personal relationships? 0.5065 0.3413
Lacked support in the ways you need from your spouse or partner? 0.5497 0.5650
Lacked support in the ways you need from your family or close friends? 0.5557 0.4769
Cognition
Unintentionally fallen asleep during the day? 0.5013 0.4569
Had problems concentrating, e.g. when reading or watching TV? 0.6104 0.4447
Felt your memory was bad? 0.7196 0.4351
Had distressing dreams or hallucinations? 0.5846 0.5028
Communication
Had difficulty with your speech? 0.6261 0.4952
Felt unable to communicate with people properly? 0.6193 0.4364
Felt ignored by people? 0.6290
Bodily discomfort
Had painful muscle cramps or spasms? 0.6063 0.4294
Had aches and pains in your joints or body? 0.5619 0.3637
Felt unpleasantly hot or cold regardless of the weather? 0.6999 0.3729
PDQ-39, Parkinson’s Disease Questionnaire.
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reason for communication demonstrating poorer agreement
with the other variables is less clear. 'e use of the word
“people” in two of the three questions in this subcategory
might be too broad. Communication entails interacting
beyond the realm of friends and family. English and Afri-
kaans are spoken by more than half of the larger community
in the study area (approximately 54%) [22], most of whom
are white, and are the primary languages used in the
workplace. Many of the study participants spoke neither
language. 'e obstacle of language, when communicating
with the general public, is not uncommon for those with low
education levels and for those educated in schools where
English is not the language of instruction.
Despite the overall good performance of the modified
questionnaires in this South African population-based study,
the study had some limitations. 'e internal consistency of the
PDSQ differed across the four languages, andmore adaptations
might be required before it is used in population-based studies.
For example, there might be overreporting of symptoms (e.g.,
smaller handwriting) due to low literacy rather than neuro-
logical problems. 'e PDQ-39 scores were lower for English
andAfrikaans speakers, which could be an indication of literacy
rather than quality of life; English and Afrikaans speakers
might be better educated and more literate than those who are
not fluent in either language.
'e use of the PDQ-39 in this screening context is
nontraditional and beyond the original intent of the ques-
tionnaire. However, the strong correlation with a clinically
meaningful motor examination from a movement disorders
specialist provides compelling evidence that the question-
naires are measuring PD-specific effects on quality of life.
While other validation studies of these questionnaires were
performed in general population samples, there is also
substantial evidence that the PDQ-39 is a valid measure of
the impact of PD on quality of life in patients with PD
[23–25]. 'e fact that our study participants were not PD
patients might explain some of the differences between our
study findings and previous reports.
In summary, our study provides strong evidence that the
modified PDQ-39 is suitable for use in epidemiological studies
investigating parkinsonism in English-, Afrikaans-, Setswana-,
and isiZulu-speaking South African communities, while the
PDSQmight need to be further modified before it can be used.
Further validation in PD patients whose primary languages are
Afrikaans, Setswana, and isiZulu will be necessary before the
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Figure 1: Association between (a) severity of parkinsonism and PDQ-39 score (ρ� 0.22); (b) severity of parkinsonism and PDSQ score




PDSQ: Parkinson’s Disease Screening Questionnaire
PDQ-39: 39-item Parkinson’s Disease Questionnaire
UPDRS3: Unified Parkinson’s Disease Rating Scale motor
subsection 3
LOWESS: Locally weighted scatterplot smoothing.
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